b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31608320</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>10</Month>\n            <Day>23</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">2522-6711</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>3</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Sep</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Mediastinum (Hong Kong, China)</Title>\n                <ISOAbbreviation>Mediastinum</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">35</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.21037/med.2019.08.02</ELocationID>\n            <Abstract>\n                <AbstractText>A greater understanding of anti-tumor immunity has resulted in rapid development of immunotherapy for a wide variety of cancers. Antibodies targeting the immune checkpoints, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed death-1 (PD-1), or its ligand (PD-L1) have demonstrated clinical activity and are approved for treatment of melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma, bladder cancer, head and neck cancers, esophageal cancer, hepatocellular carcinoma, and Hodgkin lymphoma, among others. Treatment is generally well tolerated with relatively few adverse events compared with standard treatments such as chemotherapy. However, immune activation can potentially affect any organ system and a small fraction of patients are at risk for developing severe immune-related adverse events. Immune checkpoint inhibitors (ICIs) and other immunotherapeutic modalities such as cancer vaccines are in nascent stages of development for treatment of thymic epithelial tumors (TETs). Since the thymus plays a key role in the development of immune tolerance, thymic tumors have a unique biology which can influence the risk-benefit balance of immunotherapy. Indeed, early results from clinical trials have demonstrated clinical activity, albeit at a cost of a higher incidence of immune-related adverse events, which seem to particularly affect skeletal and cardiac muscle and the neuromuscular junction. In this paper we describe the effects of thymic physiology on the immune system and review the results of clinical trials that have evaluated immunotherapy for treatment of relapsed thymoma and thymic carcinoma. We review ongoing efforts to mitigate the risk of immune-related complications in patients with TETs receiving immunotherapy and offer our thoughts for making immunotherapy a feasible alternative for treatment of thymic tumors.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Zhao</LastName>\n                    <ForeName>Chen</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rajan</LastName>\n                    <ForeName>Arun</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>Z99 CA999999</GrantID>\n                    <Agency>Intramural NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>09</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>China</Country>\n            <MedlineTA>Mediastinum</MedlineTA>\n            <NlmUniqueID>101731833</NlmUniqueID>\n            <ISSNLinking>2522-6711</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Thymoma</Keyword>\n            <Keyword MajorTopicYN="N">immune-related adverse events</Keyword>\n            <Keyword MajorTopicYN="N">immunotherapy</Keyword>\n            <Keyword MajorTopicYN="N">thymic carcinoma</Keyword>\n        </KeywordList>\n        <CoiStatement>Conflicts of Interest: The authors have no conflicts of interest to declare.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31608320</ArticleId>\n            <ArticleId IdType="doi">10.21037/med.2019.08.02</ArticleId>\n            <ArticleId IdType="pmc">PMC6788636</ArticleId>\n            <ArticleId IdType="mid">NIHMS1052730</ArticleId>\n        </ArticleIdList>\n        <?nihms?>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Clin Oncol. 2019 Aug 20;37(24):2162-2170</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29906252</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Thorac Oncol. 2018 Nov;13(11):1762-1770</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30138763</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Oncol. 2014 May 07;4:103</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24847446</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2015 Apr 3;348(6230):124-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25765070</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2014 Feb;15(2):191-200</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24439931</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cardiol Res Pract. 2010;2010:185896</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20454573</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Keio J Med. 2004 Mar;53(1):30-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15096726</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2006 Sep 29;313(5795):1960-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17008531</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2011 Dec 22;365(25):2413-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22187989</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Immunol. 2018 Jul;19(7):659-664</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29925986</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2018 Feb 1;128(2):805-815</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29337305</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Trends Immunol. 2018 Aug;39(8):624-631</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29802087</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2011 Dec 20;29(36):4820-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22105817</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2018 Jun 10;36(17):1714-1768</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29442540</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Treat Options Oncol. 2008 Dec;9(4-6):277-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19381821</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA Oncol. 2019 Jun 6;:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31169866</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2019 Mar 5;129(5):2056-2070</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30835255</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Cancer. 2016 Feb;54:139-148</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26765102</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Discov. 2016 Jul;6(7):703-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27107038</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2017 May;18(5):587-598</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28373007</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pract Neurol. 2015 Dec;15(6):456-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26201976</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mediastinum. 2019 Apr;3:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">31304461</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2018 Feb 1;36(4):342-349</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29240542</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA Oncol. 2016 Feb;2(2):234-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26633184</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2018 Mar;19(3):347-355</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29395863</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Cancer. 2016 Jun;60:210-25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27084345</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2017 Aug 3;12(8):e0182665</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28771603</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tumori. 2017 May 12;103(3):217-222</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28291902</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunotherapy. 2019 Apr;11(6):515-529</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30860441</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S137-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25396311</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2018 Feb 12;33(2):244-258.e10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29438696</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurol Sci. 2019 Apr 15;399:97-100</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30798111</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Rev Mol Diagn. 2018 Mar;18(3):297-305</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29430978</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Autoimmunity. 2010 Aug;43(5-6):413-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20380583</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2014 Nov 27;515(7528):563-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25428504</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Rep. 2014 Dec 08;4:7336</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25482724</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2011 May 20;29(15):2052-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21502553</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Med. 2018 Sep;24(9):1441-1448</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30082870</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Autoimmun Rev. 2016 Jan;15(1):82-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26408958</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S260-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20859116</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mod Pathol. 2017 Jun;30(6):826-833</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28281549</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Semin Oncol. 2012 Jun;39(3):323-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22595055</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Thorac Oncol. 2015 Mar;10(3):500-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25402569</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neuropathol Exp Neurol. 2018 Aug 1;77(8):661-664</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29850899</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Med. 2017 May 5;23(5):540-547</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28475571</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2018 Jan 1;29(1):250-255</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29045547</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Respirol Case Rep. 2013 Dec;1(2):36-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25473538</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Immunol. 2011 Apr;23(2):198-206</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21163636</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rev Allergy Immunol. 2012 Apr;42(2):135-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21246308</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Rheum Dis. 2019 Jan;78(1):150-152</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30185415</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncologist. 2013;18(11):1203-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24105749</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int Immunopharmacol. 2018 Sep;62:29-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29990692</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2018 Feb 1;128(2):715-720</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29309048</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2012 Mar 22;12(4):252-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22437870</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Rheum Dis. 2019 Nov;78(11):e129</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30242031</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neuropathology. 2013 Jun;33(3):281-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22989101</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2015 Feb;16(2):177-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25592632</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2016 May 6;352(6286):658-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27151852</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Toxicol (Phila). 2018 Jul;56(7):667-671</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29126352</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Thorac Oncol. 2015 Sep;10(9):1240-1242</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26291007</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2018 Mar 23;359(6382):1350-1355</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29567705</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2018 Jun 1;142(11):2375-2382</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29322496</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lung Cancer. 2015 May;88(2):154-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25799277</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Genet. 2019 Feb;51(2):202-206</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30643254</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'